Lista de obras - Jean Charles Nault - Dominio Público Uruguay

A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection

article

A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer

artículo científico publicado en 2016

ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway

artículo científico publicado en 2013

Adeno-associated virus in the liver: natural history and consequences in tumour development

scientific article published on 02 August 2019

Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma

artículo científico publicado en 2016

Advances in management of hepatocellular carcinoma

artículo científico publicado en 2017

Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas.

artículo científico publicado en 2018

Autoimmune-like chronic hepatitis induced by olmesartan

artículo científico publicado en 2017

Building a bridge between obesity, inflammation and liver carcinogenesis

artículo científico publicado en 2010

Cancer Gene Discovery in Hepatocellular Carcinoma: The CRISPR/CAS9 Accelerator.

artículo científico publicado en 2017

Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma

artículo científico publicado en 2019

Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma.

artículo científico publicado en 2017

ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.

artículo científico publicado en 2013

European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group

artículo científico publicado en 2016

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

artículo científico publicado en 2015

GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation

artículo científico publicado en 2011

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

artículo científico

Genetic predisposition to hepatocellular carcinoma in alcoholic cirrhosis: the NCAN-PNPLA3-lipid connection?

artículo científico publicado en 2014

Genetic profiling of hepatocellular carcinoma using next-generation sequencing.

artículo científico publicado en 2016

Genetics of hepatocellular carcinoma: the next generation

artículo científico publicado en 2013

Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression

artículo científico publicado en 2016

Genotype–Phenotype Relationships in Hepatocellular Carcinoma: p53 Inactivation Promotes Tumors With Stem Cell Features ⬇️

artículo científico publicado el 23 de marzo de 2012

Germline and somatic DICER1 mutations in familial and sporadic liver tumors.

artículo científico publicado en 2016

Health system improvement: developing regional capacity across Tennessee

scientific article published on 01 October 2010

Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma

artículo científico publicado en 2021

Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results

artículo científico publicado en 2016

Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results

scientific article published on 01 September 2016

Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution

artículo científico publicado en 2016

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions

artículo científico publicado en 2013

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression

artículo científico publicado en 2013

Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification

artículo científico publicado en 2017

Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

artículo científico publicado en 2012

Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis

artículo científico publicado en 2015

Intermediate hepatobiliary cells predict an increased risk of hepatocarcinogenesis in patients with hepatitis C virus-related cirrhosis.

artículo científico publicado en 2010

Intratumor molecular and phenotypic diversity in hepatocellular carcinoma

artículo científico publicado en 2015

Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental (90)Y Radioembolization for the Treatment of Hepatocellular Carcinoma Up to 3 cm?

artículo científico publicado en 2017

Is segmental transarterial yttrium 90 radiation a curative option for solitary hepatocellular carcinoma ≤5 cm?

artículo científico publicado en 2014

Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation

artículo científico publicado en 2016

Molecular Determinants of Prognosis in Hepatocellular Carcinoma.

artículo científico publicado en 2014

Molecular classification of hepatocellular adenoma in clinical practice

artículo científico publicado en 2017

Molecular classification of hepatocellular adenomas.

artículo científico publicado en 2013

Molecular profiling of liver tumors: classification and clinical translation for decision making

artículo científico publicado en 2014

Molecular targets for HCC and future treatments.

artículo científico publicado en 2016

NRF2/KEAP1 and Wnt/β-catenin in the multistep process of liver carcinogenesis in humans and rats.

artículo científico publicado en 2015

Next generation sequencing, inter-tumor heterogeneity and prognosis of hepatitis B related hepatocellular carcinoma

artículo científico publicado en 2014

Optimizing curative management of hepatocellular carcinoma

scientific article published on 01 February 2020

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.

artículo científico publicado en 2013

Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.

artículo científico publicado en 2014

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases

artículo científico publicado en 2018

Pathogenesis of hepatocellular carcinoma according to aetiology

artículo científico

Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis.

artículo científico publicado en 2016

Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations

artículo científico publicado en 2017

Predisposition to hepatocellular carcinoma: clues in sex chromosomes.

artículo científico publicado en 2013

Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.

artículo científico publicado en 2015

Primary liver carcinomas can originate from different cell types: a new level of complexity in hepatocarcinogenesis.

artículo científico publicado en 2013

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro

artículo científico publicado en 2017

Pulmonary Consolidations due to Secondary Syphilis with Positive Bronchial Washing Immunohistochemistry

artículo científico publicado en 2016

RSPO2 abnormal transcripts result from read-through in liver tumours with high ß-catenin activation and CTNNB1 mutations

artículo científico publicado en 2019

Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK/STAT pathway in inflammatory hepatocellular adenomas

scientific article published on 06 January 2020

Reply

scientific article published on 03 June 2015

Reply

Reports from the International Liver Cancer Association (ILCA) congress 2014.

artículo científico publicado en 2014

Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension.

artículo científico publicado en 2016

Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series

artículo científico publicado en 2017

Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.

artículo científico publicado en 2013

Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas

artículo científico publicado en 2011

Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.

artículo científico publicado en 2017

Stemness of liver cancer: From hepatitis B virus to Wnt activation

artículo científico publicado en 2016

TERT promoter mutations in primary liver tumors

artículo científico

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

artículo científico publicado en 2014

The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolization.

artículo científico publicado en 2016

The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2.

artículo científico publicado en 2016

The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.

artículo científico publicado en 2016

The end of almost 10 years of negative RCTs in advanced hepatocellular carcinoma.

artículo científico publicado en 2016

The role of telomeres and telomerase in cirrhosis and liver cancer

scientific article published on 28 June 2019

The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion.

artículo científico publicado en 2016

Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation.

artículo científico publicado en 2016

Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis

artículo científico publicado en 2019

Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors.

artículo científico publicado en 2015

When activated oncogene meets immunity: a fight to prevent liver tumor initiation

scientific article published on 01 July 2012

[Acute hepatic failure in sickle cell vaso-occlusive crisis]

artículo científico publicado en 2009

Lista de obras de Jean Charles Nault

A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection

A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer

ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway

Adeno-associated virus in the liver: natural history and consequences in tumour development

Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma

Advances in management of hepatocellular carcinoma

Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas.

Autoimmune-like chronic hepatitis induced by olmesartan

Building a bridge between obesity, inflammation and liver carcinogenesis

Cancer Gene Discovery in Hepatocellular Carcinoma: The CRISPR/CAS9 Accelerator.

Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma

Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma.

ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.

European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

Genetic predisposition to hepatocellular carcinoma in alcoholic cirrhosis: the NCAN-PNPLA3-lipid connection?

Genetic profiling of hepatocellular carcinoma using next-generation sequencing.

Genetics of hepatocellular carcinoma: the next generation

Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression

Genotype–Phenotype Relationships in Hepatocellular Carcinoma: p53 Inactivation Promotes Tumors With Stem Cell Features ⬇️

Germline and somatic DICER1 mutations in familial and sporadic liver tumors.

Health system improvement: developing regional capacity across Tennessee

Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma

Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results

Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results

Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression

Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification

Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis

Intermediate hepatobiliary cells predict an increased risk of hepatocarcinogenesis in patients with hepatitis C virus-related cirrhosis.

Intratumor molecular and phenotypic diversity in hepatocellular carcinoma

Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental (90)Y Radioembolization for the Treatment of Hepatocellular Carcinoma Up to 3 cm?

Is segmental transarterial yttrium 90 radiation a curative option for solitary hepatocellular carcinoma ≤5 cm?

Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation

Molecular Determinants of Prognosis in Hepatocellular Carcinoma.

Molecular classification of hepatocellular adenoma in clinical practice

Molecular classification of hepatocellular adenomas.

Molecular profiling of liver tumors: classification and clinical translation for decision making

Molecular targets for HCC and future treatments.

NRF2/KEAP1 and Wnt/β-catenin in the multistep process of liver carcinogenesis in humans and rats.

Next generation sequencing, inter-tumor heterogeneity and prognosis of hepatitis B related hepatocellular carcinoma

Optimizing curative management of hepatocellular carcinoma

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.

Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases

Pathogenesis of hepatocellular carcinoma according to aetiology

Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis.

Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations

Predisposition to hepatocellular carcinoma: clues in sex chromosomes.

Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.

Primary liver carcinomas can originate from different cell types: a new level of complexity in hepatocarcinogenesis.

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro

Pulmonary Consolidations due to Secondary Syphilis with Positive Bronchial Washing Immunohistochemistry

RSPO2 abnormal transcripts result from read-through in liver tumours with high ß-catenin activation and CTNNB1 mutations

Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK/STAT pathway in inflammatory hepatocellular adenomas

Reply

Reply

Reports from the International Liver Cancer Association (ILCA) congress 2014.

Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension.

Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series

Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.

Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas

Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.

Stemness of liver cancer: From hepatitis B virus to Wnt activation

TERT promoter mutations in primary liver tumors

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolization.

The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2.

The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.

The end of almost 10 years of negative RCTs in advanced hepatocellular carcinoma.

The role of telomeres and telomerase in cirrhosis and liver cancer

The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion.

Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation.

Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis

Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors.